J&J Innovative Medicine

The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.

The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its consumer, pharmaceutical and medical devices businesses.

Cold temps and dry air can wreak havoc on already stressed skin. For those with certain inflammatory skin diseases, Lloyd S. Miller, M.D., Ph.D., says following a personalized treatment plan is the key to finding more comfort this season.

It’s one of the world’s deadliest infectious diseases, killing more people each year than HIV/AIDS and malaria combined. We’re taking a look back at the strides the company has made in fighting this preventable illness to help bring us closer to a tuberculosis-free world.

From Fast Company‘s 2020 Best Workplaces for Innovators to Interbrand‘s Best Global Brands of 2020, learn about some of the distinctions that the company has been honored with this year for its work to help people and communities around the world.

Taubert, who has helped guide the Janssen Pharmaceutical Companies of Johnson & Johnson during the COVID-19 pandemic, has been honored on the annual list for the fifth year in a row.

Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

For the 35th year in a row, Johnson & Johnson has been named to Working Mother’s 100 Best Companies list—and these two employees were named Working Mother and Working Dad of the Year for their incredible strength in the face of adversity.

Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., were just honored with the prestigious award for their work with gene-editing technology CRISPR. But they also have a connection to Johnson & Johnson—they were awarded the Dr. Paul Janssen Award in 2014. Learn more about what makes them so impressive.